Glioblastoma (GBM) is a type of intracranial brain tumor, for which there is no cure. In spite of
advances in surgery, chemotherapy and radiotherapy, patients die within a year of …

Glioblastoma multiforme (GBM) is the most common primary brain cancer in adults. Despite
significant advances in treatment and intensive research, the prognosis for patients with …

An authoritative panel of researchers and clinicians critically reviews the entire field to
provide a comprehensive guide to modern brain tumor immunotherapy and thereby …

The immunologic treatment of cancer has long been heralded as a targeted molecular
therapeutic with the promise of eradicating tumor cells with minimal damage to surrounding …

Glioblastoma multiforme (GBM) is the most common and deadliest of adult primary brain
tumors. Due to its invasive nature and sensitive location, complete resection remains …

Harnessing the effector mechanisms of the immune system to combat brain tumors with
antigen specificity and memory has been in research and clinical testing for many years …

Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy,
Second Edition, provides a comprehensive overview of the molecular methodologies in the …

Malignant brain tumors represent one of the most devastating forms of cancer with abject
survival rates that have not changed in the past 60 years. This is partly because the brain is …

Malignant gliomas, including glioblastoma (GBM) as the most aggressive type of adult CNS
tumors, are notoriously resistant to current standard of care treatments, including surgery …

Glioblastoma (GBM) is the most lethal form of brain tumor and remains a large, unmet
medical need. This review focuses on recent advances in the neurosciences that converge …